An Open-Label, Dose Escalation Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of AMG 102 with AMG 706 and AMG 102 with Bevacizumab in Adult Subjects With Advanced Solid Tumors

Sponsor ID

20050177

Clinicaltrials.gov ID

EUCTIS ID

N/A

EudraCT ID

N/A

Study Details

Phase

N/A

Product

rilotumumab

Type

Interventional

Masking

N/A

Enrollment

N/A

Additional Study Details

Primary Outcome Measures

Not Available

Secondary Outcome Measures

Not Available

Study Synopsis

Available Language(s): English

No locations found.